(Q60168187)

English

Acute haemodynamic responses to inhaled nitric oxide and intravenous sildenafil in distal chronic thromboembolic pulmonary hypertension (CTEPH)

article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17368113%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Acute haemodynamic responses to inhaled nitric oxide and intravenous sildenafil in distal chronic thromboembolic pulmonary hypertension (CTEPH) (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17368113%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Chronic Thromboembolic Pulmonary Hypertension

0 references

1 reference

based on heuristic

inferred from title

thromboembolism

1 reference

based on heuristic

inferred from title

Kimberley A. Goldsmith

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17368113%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

J Suntharalingam

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17368113%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

R J Hughes

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17368113%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

N Doughty

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17368113%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

P George

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17368113%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

M Toshner

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17368113%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

K K Sheares

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17368113%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

J Pepke-Zaba

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17368113%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

publication date

12 February 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17368113%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Vascular Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17368113%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

46

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17368113%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17368113%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

449-455

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17368113%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.01.008

7 January 2021

Continuous intravenous epoprostenol for chronic thromboembolic pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.01.008

7 January 2021

Medical therapies for chronic thromboembolic pulmonary hypertension: an evolving treatment paradigm

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.01.008

7 January 2021

Cyclic GMP phosphodiesterase-5: target of sildenafil

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.01.008

7 January 2021

Sildenafil citrate therapy for pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.01.008

7 January 2021

Sildenafil for long-term treatment of nonoperable chronic thromboembolic pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.01.008

7 January 2021

DOSE RESPONSE OF INTRAVENOUS SILDENAFIL ON SYSTEMIC AND REGIONAL HEMODYNAMICS IN HYPOXIC NEONATAL PIGLETS

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.01.008

7 January 2021

Goal-oriented treatment and combination therapy for pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.01.008

7 January 2021

The efficacy of bosentan in inoperable chronic thromboembolic pulmonary hypertension: a 1-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.01.008

7 January 2021

Effects of sildenafil citrate on human hemodynamics.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.01.008

7 January 2021

Pulmonary endarterectomy: experience and lessons learned in 1,500 cases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.01.008

7 January 2021

Current treatment strategies for pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.01.008

7 January 2021

Prognostic factors in medically treated patients with chronic pulmonary embolism

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.01.008

7 January 2021

Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.01.008

7 January 2021

Clinical and haemodynamic effects of sildenafil in pulmonary hypertension: acute and mid-term effects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.01.008

7 January 2021

Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.01.008

7 January 2021

Pharmacokinetics of sildenafil after single oral doses in healthy male subjects: absolute bioavailability, food effects and dose proportionality

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.01.008

7 January 2021

Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.01.008

7 January 2021

Acute and chronic effects of sildenafil in patients with pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.01.008

7 January 2021

The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.01.008

7 January 2021

Longterm follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.01.008

7 January 2021

Effect of intravenous sildenafil on pulmonary hemodynamics and gas exchange in the presence and absence of acute lung injury in piglets

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.01.008

7 January 2021

Clinical classification of pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.01.008

7 January 2021

Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.01.008

7 January 2021

Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.01.008

7 January 2021

Pulmonary thromboendarterectomy--risk factors for early survival and hemodynamic improvement

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.01.008

7 January 2021

Chronic thromboembolic and pulmonary arterial hypertension share acute vasoreactivity properties

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.01.008

7 January 2021

Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.01.008

7 January 2021

Chronic thromboembolic pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.01.008

7 January 2021

Distribution of obstructive intimal lesions and their cellular phenotypes in chronic pulmonary hypertension. A morphometric and immunohistochemical study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2007.01.008

7 January 2021

Identifiers

10.1016/J.VPH.2007.01.008

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17368113%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17368113%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q60168187&oldid=2120303982"